Drug details

Brevibloc (esmolol)

type of Beta-Blockers, Beta-1 Selective

Brevibloc Premixed (esmolol hydrochloride) Injection is a beta-blocker indicated for the rapid control of ventricular rate in patients with atrial fibrillation, or atrial flutter in perioperative, postoperative, or other emergent circumstances. Brevibloc is also indicated in noncompensatory sinus tachycardia where the rapid heart rate requires specific intervention. Brevibloc is available in generic form.

This drug may have the following side effects:

• low blood pressure (hypotension).

The following drugs are related to Brevibloc, either as a replacement or used together:

• Lanoxin Injection (digoxin injection)
• Lanoxin (digoxin tablets)
• Taztia XT (diltiazem hydrochloride extended release tablets)
• Lopressor (metoprolol tartrate)
• Toprol XL (metoprolol succinate)

The following supplements are related to Brevibloc, and may be used together with the drug:

• Alpha-Linolenic Acid (s.)
• Calcium (s.)
• Coenzyme Q-10 (s.)
• Olive (s.)
• Potassium (s.)
• Sweet Orange (s.)
• Iron (s.)
• Blond Psyllium (s.)
• Cocoa (s.)
• Cod Liver Oil (s.)
• Garlic (s.)
• Pycnogenol (s.)
• Stevia (s.)
• Wheat Bran (s.)